Literature DB >> 1259521

The effect of neuroleptics on serum prolactin in schizophrenic patients.

H Y Meltzer, V S Fang.   

Abstract

Serum prolactin levels were studied before and during long-term administration of phenothiazines on a twice daily schedule to 27 newly admitted schizophrenic patients. An increase in serum prolactin is believed to be a reflection of inhibition of dopamine receptors in the hypothalamopituitary axis. By 72 hours after the initiation of treatment, all 27 patients had persistently elevated serum prolactin levels averaging 3.2-fold and 3.8-fold in men and women, respectively. There was a lag between clinical response and dopamine blockade, as indicated by serum prolactin levels in most patients. Serum prolactin levels remained elevated during the one- to three-month period subjects were studied, suggesting there was no tolerance to this effect of phenothiazines. Serum prolactin levels tended to be higher with thioridazine than on equivalent doses of chlorpromazine or trifluoperazine hydrochloride. There was some evidence that the magnitude of the serum prolactin elevation correlated with clinical response. After cessation of phenothiazines, serum prolactin levels rapidly reverted to normal within 48 to 96 hours.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1259521     DOI: 10.1001/archpsyc.1976.01770030003001

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  56 in total

1.  Hyperprolactinaemia caused by antipsychotic drugs.

Authors:  Angelika Wieck; Peter Haddad
Journal:  BMJ       Date:  2002-02-02

Review 2.  Basic biology of clozapine: electrophysiological and neuroendocrinological studies.

Authors:  G A Gudelsky; J F Nash; S A Berry; H Y Meltzer
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

3.  The atypical antipsychotics olanzapine and quetiapine, but not haloperidol, reduce ACTH and cortisol secretion in healthy subjects.

Authors:  Stefan Cohrs; Cornelia Röher; Wolfgang Jordan; Andreas Meier; Gerald Huether; Wolfgang Wuttke; Eckart Rüther; Andrea Rodenbeck
Journal:  Psychopharmacology (Berl)       Date:  2006-01-24       Impact factor: 4.530

4.  An open study of tolerability and pharmacokinetics of raclopride extended release capsules in psychiatric patients: a Canadian study.

Authors:  A Gendron; G Sirois; N P Nair; D Bloom; G Movin-Osswald; G Uppfeldt
Journal:  J Psychiatry Neurosci       Date:  1995-07       Impact factor: 6.186

5.  Characterization of [3H]clozapine binding sites in rat brain.

Authors:  I Kusumi; S Matsubara; Y Takahashi; T Ishikane; T Koyama
Journal:  J Neural Transm Gen Sect       Date:  1995

6.  Relationships between clinical and biochemical effects of melperone and thiothixene in psychotic women.

Authors:  L Bjerkenstedt; B Gullberg; C Härnryd; G Sedvall
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1979

7.  Neuroendocrine profile of SDZ HDC-912 and OPC-4392, two new atypical antipsychotic drugs, in schizophrenic patients.

Authors:  F Duval; M C Mokrani; J P Macher; M A Crocq; J O Castro; P Bailey; X Lataste
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  Extrapyramidal side effects and increased serum prolactin following fluoxetine, a new antidepressant.

Authors:  H Y Meltzer; M Young; J Metz; V S Fang; P M Schyve; R C Arora
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575

9.  EEG and behavioral profile of flutroline (CP-36,584), a novel antipsychotic drug.

Authors:  M Fink; P Irwin
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

10.  Autocrine prolactin: an emerging market for homegrown (prolactin) despite the imports.

Authors:  Senthil K Muthuswamy
Journal:  Genes Dev       Date:  2012-10-15       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.